Canada Pension Plan Investment Board Affimed N.V. Transaction History

Canada Pension Plan Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.27 - $4.86 $349,580 - $748,440	-154,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.69 - $5.65 $354,240 - $542,400	-96,000 Reduced 38.4%	154,000 $673,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $7.07 $719,580 - $947,380	-134,000 Reduced 34.9%	250,000 $1.38 Million
Q2 2021 Aug 16, 2021	SELL	$7.78 - $11.4 $5.24 Million - $7.67 Million	-673,000 Reduced 63.67%	384,000 $3.26 Million
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $4.18 Million - $6.92 Million	816,000 Added 338.59%	1,057,000 $8.36 Million
Q4 2020 Feb 17, 2021	BUY	$3.16 - $7.03 $761,560 - $1.69 Million	241,000 New	241,000 $1.4 Million
Q3 2019 Nov 12, 2019	SELL	$2.67 - $3.65 $534,000 - $730,000	-200,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$2.6 - $4.21 $520,000 - $842,000	200,000 New	200,000 $574,000
Q3 2018 Nov 09, 2018	SELL	$1.45 - $6.15 $145,000 - $615,000	-100,000 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$1.65 - $2.5 $165,000 - $250,000	100,000 New	100,000 $165,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $166M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.